Profile | GDS4284 / 211287_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 183.287 | 48 |
GSM687648 | Patient 402 control | 303.754 | 56 |
GSM687653 | Patient 403 control | 150.866 | 44 |
GSM687658 | Patient 404 control | 322.552 | 57 |
GSM687663 | Patient 411 control | 350.279 | 57 |
GSM687668 | Patient 422 control | 301.974 | 56 |
GSM687673 | Patient 424 control | 523.557 | 64 |
GSM687678 | Patient 425 control | 288.37 | 54 |
GSM687683 | Patient 427 control | 691.408 | 68 |
GSM687688 | Patient 428 control | 176.272 | 46 |
GSM687695 | Patient 441 control | 2021.27 | 85 |
GSM687699 | Patient 443 control | 506.865 | 63 |
GSM687704 | Patient 444 control | 354.938 | 58 |
GSM687707 | Patient 448 control | 243.295 | 49 |
GSM687712 | Patient 449 control | 329.617 | 57 |
GSM687719 | Patient 450 control | 565.81 | 64 |
GSM687724 | Patient 451 control | 268.569 | 52 |
GSM687728 | Patient 452 control | 785.684 | 71 |
GSM687646 | Patient 401 treated 24h | 130.842 | 40 |
GSM687649 | Patient 402 treated 24h | 254.984 | 54 |
GSM687665 | Patient 411 treated 24h | 489.342 | 63 |
GSM687651 | Patient 402 treated 4 weeks | 288.036 | 54 |
GSM687667 | Patient 411 treated 4 weeks | 381.517 | 59 |
GSM687670 | Patient 422 treated 24h | 641.505 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 366.407 | 59 |
GSM687654 | Patient 403 treated 24h | 96.5994 | 36 |
GSM687675 | Patient 424 treated 24h | 517.715 | 63 |
GSM687685 | Patient 427 treated 24h | 290.819 | 55 |
GSM687656 | Patient 403 treated 4 weeks | 73.9594 | 31 |
GSM687677 | Patient 424 treated 4 weeks | 229.309 | 51 |
GSM687687 | Patient 427 treated 4 weeks | 216.751 | 51 |
GSM687692 | Patient 428 treated 4h | 149.001 | 42 |
GSM687716 | Patient 449 treated 4h | 118.07 | 38 |
GSM687722 | Patient 450 treated 4h | 293.226 | 53 |
GSM687680 | Patient 425 treated 24h | 387.931 | 59 |
GSM687690 | Patient 428 treated 24h | 253.477 | 54 |
GSM687700 | Patient 443 treated 24h | 1221.24 | 77 |
GSM687705 | Patient 444 treated 24h | 370.546 | 60 |
GSM687714 | Patient 449 treated 24h | 232.987 | 52 |
GSM687721 | Patient 450 treated 24h | 823.023 | 71 |
GSM687682 | Patient 425 treated 4 weeks | 279.617 | 55 |
GSM687694 | Patient 428 treated 4 weeks | 161.496 | 46 |
GSM687702 | Patient 443 treated 4 weeks | 787.477 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 231.289 | 51 |
GSM687723 | Patient 450 treated 4 weeks | 359.9 | 58 |
GSM687661 | Patient 404 treated 4h | 259.183 | 52 |
GSM687710 | Patient 448 treated 4h | 186 | 47 |
GSM687726 | Patient 451 treated 4h | 219.067 | 47 |
GSM687730 | Patient 452 treated 4h | 221.999 | 35 |
GSM687660 | Patient 404 treated 24h | 1074.26 | 77 |
GSM687697 | Patient 441 treated 24h | 1382.6 | 80 |
GSM687709 | Patient 448 treated 24h | 420.972 | 61 |
GSM687725 | Patient 451 treated 24h | 275.377 | 51 |
GSM687729 | Patient 452 treated 24h | 1840.93 | 84 |
GSM687727 | Patient 451 treated 4 weeks | 170.334 | 42 |
GSM687731 | Patient 452 treated 4 weeks | 681.609 | 68 |